In This Section      


The Neuro-Ophthalmology division of the Johns Hopkins Wilmer Eye Institute specializes in patients with blurred vision caused by optic disorders, double vision caused by strokes and brain tumors, defects in the visual fields, and involuntary spasms of the face and eyelids. 

A variety of eye disorders are caused by or associated with neurologic diseases, such as multiple sclerosis, strokes and brain tumors. Because this specialty includes the fields of ophthalmology, neurology, neurosurgery and neuroradiology, most neuro-ophthalmologists have received training in all of these areas.

appointment icon

Request an Appointment:   410-955-8679

Patients referred to our division receive a complete evaluation, including:

  • Testing of visual acuity
  • Color vision testing
  • Evaluation of the eye movements and ocular alignment
  • Visual field testing using kinetic perimetry, static perimetry, or both
  • Evaluation of visual dysfunction after brain injury

Selected patients may also undergo a variety of other diagnostic tests, including echography, CT scanning, and MR imaging. Upon completion of the evaluation, recommendations for further testing, therapy or both are given to the patient and referring physician, and a complete typed report is sent to the referring physician.

stroke scan
Conditions We Treat
Learn more about the conditions caused by or associated with neurologic diseases that our expert faculty treat.
Dr. Bosley
Our Team
Meet the experts who diagnose, treat, and research basic and complex neuro-ophthalmic conditions.
stem cells
Our Research
Explore our research that aims to advance the prevention and treatment of neuro-ophthalmic disorders.

News and Events

I looked down, saw two left hands and four feet, closed one eye and keeled over- The Washington Post

Washington Post journalist Frances Stead Sellers describes her experience with double vision and how Amanda Henderson, M.D., diagnosed and treated her sixth nerve palsy. Read more.

New Study to Use Celecoxib (Celebrex®) as Treatment for Thyroid Eye Disease

Timothy McCulley, M.D., will lead a study that uses celecoxib, a nonsteroidal, anti-inflammatory drug, as an alternative early treatment for thyroid eye disease. The study is funded by the Oliver and Harriet Sockwell Foundation, which focuses on health and education issues. Learn More.

Request an Appointment

Maryland Patients



Traveling for Care?

Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Outside of Maryland (toll free)

Request an Appointment
Medical Concierge Services

International Patients

Request an Appointment
Medical Concierge Services

blue suitcase